v3.20.4
Stockholders' Equity and Earnings per Share (Tables)
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Schedule of Cash Dividends
The following dividends were declared in 2020, 2019 and 2018 under NXP’s quarterly dividend program which was introduced as of the third quarter of 2018:
202020192018
Dividends declared (in millions)420 351 147 
Dividends declared (per share)1.50 1.25 0.50 
Schedule of Transactions from Employee Option and Share Plans
The following transactions took place resulting from employee option and share plans:
202020192018
Total shares in treasury at beginning of year34,082,242 35,913,021 3,078,470 
Total cost3,037 3,238 342 
Shares acquired under repurchase program4,828,913 15,865,718 54,376,181 
Average price in $ per share129.7 90.94 92.07 
Amount paid627 1,443 5,006 
Shares delivered3,866,203 4,513,416 4,241,487 
Average price in $ per share94.26 93.55 107.75 
Amount received71 84 39 
Shares retired26,000,000 13,183,081 17,300,143 
Total shares in treasury at end of year9,044,952 34,082,242 35,913,021 
Total cost1,037 3,037 3,238 
Computation of Earnings per Share (EPS)
The computation of earnings per share (EPS) is presented in the following table:
202020192018
Net income (loss)80 272 2,258 
Less: Net income (loss) attributable to non-controlling interests28 29 50 
Net income (loss) attributable to stockholders52 243 2,208 
Weighted average number of shares outstanding (after deduction of treasury
shares) during the year (in thousands)
279,763 282,056 325,781 
Plus incremental shares from assumed conversion of:
Options 1)
526 776 1,145 
Restricted Share Units, Performance Share Units and Equity Rights 2)
3,520 3,079 1,680 
Dilutive potential common share4,046 3,855 2,825 
Adjusted weighted average number of shares outstanding (after deduction of treasury shares) during the year (in thousands) 1)
283,809 285,911 328,606 
EPS attributable to stockholders in $:
Basic net income (loss)0.19 0.86 6.78 
Diluted net income (loss)0.18 0.85 6.72 
1)No stock options to purchase shares of NXP’s common stock that were outstanding in 2020 (2019: 0.1 million shares; 2018: 0.1 million shares) were anti-dilutive and were not included in the computation of diluted EPS because the exercise price was greater than the average fair market value of the common stock or the number of shares assumed to be repurchased using the proceeds of unrecognized compensation expense and exercise prices was greater than the weighted average number of shares underlying outstanding stock options.
2)Unvested RSU’s, PSU’s and equity rights of 0.6 million shares that were outstanding in 2020 (2019: 0.7 million shares; 2018: 0.9 million shares) were anti-dilutive and were not included in the computation of diluted EPS because the number of shares assumed to be repurchased using the proceeds of unrecognized compensation expense was greater than the weighted average number of outstanding unvested RSU’s, PSU’s and equity rights or the performance goal has not been met.